Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 USD | -1.31% | +4.95% | +44.10% |
04-30 | Enanta Pharmaceuticals, Inc. Appoints Matthew P. Kowalsky as Chief Legal Officer | CI |
02-09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.10% | 291M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ENTA Stock
- News Enanta Pharmaceuticals, Inc.
- Earnings Flash (ENTA) ENANTA PHARMACEUTICALS Reports Q3 Revenue $19.5M